On Mar 2, 2022 Hookipa Pharma closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors .

About the company: Hookipa Pharma is located at Austria, Europe.
“Hookipa Pharma Inc. is a clinical stage company developing products to prevent and cure infectious diseases and cancer. With this goal in mind, we created unique and cutting-edge technologies to reprogram and stimulate the immune system. ”

Company website: http://www.hookipapharma.com